Skip to main content

INTERESTED IN INVESTING? JOIN AN UPCOMING EVENT REGISTER →

Latest Blogs

May 22, 2026

The Coherence Gap in Women's Health — and Why It's an Investor's Moment

The companies that are building toward coherence by connecting care across life stages, integrating data and clinical support, meeting women as they are rather than fitting them into legacy categories, are the ones that will define the next decade of this sector.

Read More

Next

May 15, 2026

Women’s Health Week: Investing in the Future of Women’s Care

This Women’s Health Week, we celebrate the founders, healthcare professionals, researchers, and investors pushing the industry forward — and the women whose voices, experiences, and needs are finally driving the future of healthcare innovation.

Read More

Next

May 8, 2026

The Fertility Gap No One Is Talking About

Infertility affects millions of women around the world, it's a global reality that we've taken steps to change.

Read More

Next

April 22, 2026

Earth Day Appreciation: How We're Addressing the Climate Crisis

This Earth Day, we’re highlighting one company that brings all of those themes together: Kind Designs.

Read More

Next

December 22, 2025

What YourChoice Therapeutics Means for Contraception Innovation

YourChoice’s YCT-529, a non-hormonal male birth control pill, is entering human trials and reshaping contraception for impact-driven women's health investors.

Read More

Next

December 19, 2025

Beyond Fertility: The Mental Health Crisis in Women's Healthcare

Mental health in women is underdiagnosed and underfunded; why it matters for investors and how Portfolia is backing women-centered solutions.

Read More

Next

December 19, 2025

AI in Women’s Health: Personalized Care Is Finally Here

AI in women’s health is turning late, generic care into personalized pathways. See how investors back this shift through Portfolia’s women’s health funds.

Read More

Next

December 12, 2025

How Mirvie Is Predicting Pregnancy Complications Before They Happen

Mirvie’s RNA-based test is redefining pregnancy risk prediction and why Portfolia views it as a pivotal investment in the future of maternal health.

Read More

Next

December 12, 2025

Closing the Gender Health Gap: A One Trillion Dollar Opportunity

Women make up half the population and drive most healthcare decisions, yet they face worse outcomes across many conditions. The cost of that gap is enormous.

Read More

Next

December 12, 2025

Why Women’s Health Gets Just Two Percent of VC Funding And What We Are Doing About It

Women’s health gets just 2 percent of healthcare VC while women drive 80 percent of medical decisions. Learn why this trillion dollar opportunity matters for investors and how Portfolia is changing the numbers.

Read More

Next

December 5, 2025

Autoimmune Diseases in Women: Why They Suffer Most and How Innovation Is Fighting Back

Autoimmune diseases strike 78% of women yet remain underfunded. This piece breaks down the market, emerging innovations and how investors can partner with Portfolia’s women’s health funds.

Read More

Next

December 4, 2025

From Two Weeks to Two Days: How Gameto Is Revolutionizing IVF for Patients and Investors

Gameto cuts IVF from two weeks of shots to a few days, and Portfolia breaks down why this technology is a powerful opportunity for women's health investors.

Read More

Next

November 27, 2025

Heart Disease Is Still the Number One Killer of Women: What Is Finally Changing for Women's Heart Health and Investors

Heart disease kills 1 in 3 women, yet few startups focus on women’s heart health. Investing in cardiac innovation is critical, and Portfolia is leading the way.

Read More

Next

November 25, 2025

The $180 Billion Endometriosis Opportunity: Why Investors Are Still Early to This Women's Health Market

Learn how endometriosis is a major underfunded women’s health market and how Portfolia can help investors back diagnostics, treatments, and better care.

Read More

Next

November 24, 2025

The Menopause Innovation Gap: Why Smart Investors Are Funding Solutions for 65 Million Women

The menopause market could explode from $5 billion to $40 billion by 2030—here's why accredited investors are paying attention

Read More

Next

November 21, 2025

The Future of Contraception: Why Portfolia is Backing Innovation in Women's Health

Learn how new contraception including the first non hormonal male birth control pill can reduce unintended pregnancies and why Portfolia backs this shift in womens health investing

Read More

Next

November 20, 2025

The Invisible Epidemic: Why Osteoporosis Represents a Critical Investment Opportunity in Women's Health

See why osteoporosis is an overlooked women’s health crisis and investment opportunity, and how Portfolia’s women led funds back bone health innovators.

Read More

Next

November 18, 2025

Breaking Down Barriers: How b.well Is Revolutionizing Women's Health Through True Interoperability?

Learn how b.well Connected Health use unified health data to close gaps in women’s care, prevent avoidable harm, and power better decisions.

Read More

Next

November 14, 2025

The Silent Killer: Fighting Ovarian Cancer Through Innovation and Investment

Invest in ovarian cancer innovation with Portfolia’s women-led funds, backing early detection, smarter diagnostics, and treatments that can save more lives.

Read More

Next

November 13, 2025

Menopause Care and Investing: How Portfolia Is Backing the Future of Midlife Women’s Health?

Invest in better menopause care with Portfolia’s women-led funds, backing solutions that ease symptoms, protect careers, and support midlife health.

Read More

Next

November 12, 2025

Investing in Fertility: Supporting the Next Generation of Family Building

Invest in the future of fertility and family building. Understand how Portfolia’s women-led funds back IVF, hormone, and reproductive health innovators.

Read More

Next